The legacy of Viagra and its effect on the pharmaceutical landscape presents a intriguing question for shareholders . Initially a massive drug, copycat medications have significantly eroded its market share , creating obstacles for companies connected to the original patent holder and similar advancements . While certain businesses might benefit fr